Compare BMRN & EMBJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BMRN | EMBJ |
|---|---|---|
| Founded | 1996 | 1969 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 11.8B |
| IPO Year | 1999 | N/A |
| Metric | BMRN | EMBJ |
|---|---|---|
| Price | $53.06 | $64.15 |
| Analyst Decision | Buy | |
| Analyst Count | 19 | 0 |
| Target Price | ★ $88.42 | N/A |
| AVG Volume (30 Days) | ★ 2.9M | 888.0K |
| Earning Date | 10-27-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 0.08% |
| EPS Growth | ★ 59.53 | N/A |
| EPS | ★ 2.68 | 0.45 |
| Revenue | $3,094,001,000.00 | ★ $7,746,796,250.00 |
| Revenue This Year | $13.39 | N/A |
| Revenue Next Year | $7.57 | $10.84 |
| P/E Ratio | ★ $19.89 | $34.44 |
| Revenue Growth | 12.39 | ★ 31.44 |
| 52 Week Low | $50.76 | $34.88 |
| 52 Week High | $73.51 | $67.44 |
| Indicator | BMRN | EMBJ |
|---|---|---|
| Relative Strength Index (RSI) | 46.21 | N/A |
| Support Level | $52.55 | N/A |
| Resistance Level | $54.33 | N/A |
| Average True Range (ATR) | 1.24 | 0.00 |
| MACD | -0.17 | 0.00 |
| Stochastic Oscillator | 19.23 | 0.00 |
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment.